Whitehawk Therapeutics (WHWK) Other Operating Expenses (2019 - 2025)

Whitehawk Therapeutics (WHWK) has 5 years of Other Operating Expenses data on file, last reported at -$177000.0 in Q3 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$177000.0 in Q3 2025; TTM through Mar 2026 was -$177000.0, a 100.2% decrease from a year earlier, with the FY2025 full-year figure at $87.3 million, changed N/A from the prior year.
• Other Operating Expenses for Q3 2025 stood at -$177000.0, down from $87.4 million in the prior quarter.
• Over the last five years, Other Operating Expenses for WHWK reached as high as $87.4 million in Q1 2025 and fell as low as -$177000.0 in Q3 2025.
• Historically, Other Operating Expenses has averaged $15.4 million across 4 years, with a median of $656000.0 in 2023.
• Across the five-year window, Other Operating Expenses sank 99.2% in 2022 and surged 317.57% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at $74.2 million in 2021, then plunged by 99.7% to $222000.0 in 2022, then soared by 317.57% to $927000.0 in 2023, then slumped by 119.09% to -$177000.0 in 2025.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$177000.0 in Q3 2025, $87.4 million in Q1 2025, and $927000.0 in Q4 2023.